|
continued
Raplon:
This muscular block injection was used to help intubation
prior to surgery, however, it had to be withdrawn
from the market after it caused a number of fatalities
and serious cardio pulmonary reactions. Prior to its
withdrawal Raplon was given to about a million patients.
Lotronex:
This medication, used to treat irritable bowel syndrome
in women, was withdrawn after reports of serious adverse
effects, including multiple deaths, but it is now
back on the market. An investigative article published
by the Los Angeles Times in November, 2000 found that
multiple patients developed potentially life threatening
complications as a result of ingesting Lotronex. The
FDA chose a paid consultant from Glaxo Wellcome, Lotronexs
manufacturer, to serve with an advisory committee
that recommended approval of the drug. Further, the
FDA permitted GlaxoWellcome to put Lotronex on the
market without conducting a major new study of its
link to ischemic colitis, a potentially fatal condition.
Posicor:
This heart failure treatment was placed on the market
despite increased numbers of sudden cardiac deaths
in people using the drug. It was not withdrawn from
the market until after 600,000 people had been prescribed
it. Swedish authorities had taken Posicor off the
market in 1997. The FDA, however, approved use of
the drug, despite over 140 deaths in patients in an
ongoing study. Posicor was withdrawn from the market
less than one year after being FDA approved. By the
time it was withdrawn reports indicated it was linked
to 100 deaths, and patients who had been prescribed
Posicor died at a rate of about 10% greater than those
who were prescribed its competitor.
Hismanal:
This antihistamine manufactured by Janssen Pharmaceuticals,
was withdrawn from the market after severe cardiovascular
events and potentially life threatening reactions
to the drug were reported.
|
Hismanal
has been associated with the risk of death due to
irregular heart rhythms when taken in combination
with other drugs.
Seldane:
This commonly used prescription antihistamine, was
withdrawn from the market in 1997. Even though Seldane
was linked to a large number of cases of fatal or
near fatal heart arrhythmias, the FDA waited to withdraw
this drug until its manufacturer, Hoechst Marion Rouffel,
received approval for the marketing of Allegra, a
different antihistamine.
Raxar:
An antibiotic used in the treatment of an estimated
2.65 million patients, was withdrawn as a result of
severe cardiovascular events and deaths amongst patients.
By the time of its withdrawal, this drug had generated
$23 million in sales for its manufacturer Glaxo Wellcome,
Inc., now known as Glaxo Smith Kline, according to
an L.A. Times Article.
Given the
frightening number of drugs withdrawn for safety issues,
one must question the power which drug companies wield
with the FDA and whether they are rushing new products
to the market.
With high
pressure marketing campaigns, drug companies can rack
up millions in sales on drugs even if they are only
on the market for a short time. However, the cost
to the patients who are prescribed dangerous medications
is simply too high to bear.
If you,
or a family member, has been injured by a dangerous
drug you can call Bonina & Bonina, P.C. for a
free consultation at 1-888-MEDLAW1.
|
Trial Lawyers Care:
Helping 9/11 Victims
Like
all Americans, our first reactions to the events
of September 11th were shock, horror and grief.
Then we
asked how we could best help those who lost loved
ones or were themselves injured by this heinous terrorist
act.
We found
a way: by volunteering with Trial Lawyers Care, Inc.
This is a nonprofit corporation set up by volunteer
trial lawyers across the nation to provide free representation
to the victims of September 11th in their claims before
the Victims Compensation Fund.
Each attorney
at Bonina & Bonina, P.C. has committed to representing
pro bono clients assigned through Trial Lawyers Care.
John Bonina
recently had his first meeting with Special Master
Feinberg on behalf of the children of a man killed
in the World Trade Center attack. This claim was among
the first sixteen claims being presented to the fund
by Trial Lawyers Care. All of the attorneys at the
firm are working hard to expedite the claims that
they have been assigned.
Like all
of the over 2,000 attorneys who have already volunteered
with Trial Lawyers Care, our goal is simply to help
the victims rebuild their lives.
We urge
all members of the legal community to volunteer to
help on a pro bono basis with Trial Lawyers Care,
Inc. Any attorneys wishing to volunteer can contact
Trial Lawyers Care at (917) 464-0105 or at www.911lawhelp.org.
Victims
of the attack should not hesitate to reach out to
Trial Lawyers Care for free legal help either at the
above number or at the above listed website.
|